E. Saad

Comparison between hypo-fractionated dose-escalated volumetric modulated arc therapy and conventional concurrent chemo-radiation in locally advanced head and neck cancer: a pilot study

E. Saad, R. Radwan, E. A. Hadi, 2020, Journal of Radiotherapy in Practice.

Dosimetric Comparison of Pelvic Bone Marrow Preservation between Volumetric-Modulated Arc Therapy and Intensity-Modulated Radiotherapy in Radical Radiotherapy of High-Risk Prostate Cancer

K. Elshahat, E. Saad, Hussein M. Metwally, 2019, Research in Oncology.

Outcomes for Patients with Glioblastoma Multiforme Treated with Chemoradiation Alone or Chemoradiation Followed by Adjuvant Chemotherapy

M. Haddad, A. Amin, E. Saad, 2014 .

Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma

Lamia Mansour, E. Saad, Amaal A Abdelaal, 2022, Asian Pacific journal of cancer prevention : APJCP.

The value of quantitative pentavalent 99mTc-dimercaptosuccinic acid scan in predicting progression-free survival and overall survival in patients with glioblastoma multiforme

E. Saad, A. Badawy, A. Kandeel, 2020, Journal of Radiotherapy in Practice.

Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?

A. Monier, A. Amin, E. Saad, 2014, Journal of Neuro-Oncology.

Hypofractionated Accelerated Radiotherapy with Concurrent Chemotherapy Versus Conventional Fractionation for LAHNSCC Using IMRT/VMAT: A Pilot Study

E. Saad, E. Habib, K. Mashhour, 2023, Clinical Cancer Investigation Journal.

3D-CRT Versus SIB IMRT Acute Toxicity Outcomes in Preoperative Concurrent Chemo-Radiotherapy for Locally Advanced Rectal Cancer

W. Hashem, E. Saad, K. Mashhour, 2023, Clinical Cancer Investigation Journal.